In NSCLC patients, it has been revealed a highly significant incidence of the R248W genotype compared to the control group [ 54 ], as well as strong evidence of a significant correlation between IDO2 expression and poor NSCLC prognosis [ 40 ].
1
—
—
In NSCLC patients, it has been revealed a highly significant incidence of the R248W genotype compared to the control group [ 54 ], as well as strong evidence of a significant correlation between IDO2 expression and poor NSCLC prognosis [ 40 ].